share_log

Fate Therapeutics | 8-K: Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

SEC announcement ·  Feb 26 16:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more